Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China
about
Demography and disease characteristics of prostate cancer in IndiaInsights into Chemoresistance of Prostate CancerEast meets West: ethnic differences in prostate cancer epidemiology between East Asians and CaucasiansInvolvement of apoptotic pathways in docosahexaenoic acid-induced benefit in prostate cancer: Pathway-focused gene expression analysis using RT2 Profile PCR Array System.When to perform bone scintigraphy in patients with newly diagnosed prostate cancer? a retrospective studyTumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells.The burden of prostate cancer in Asian nations.Arg-Gly-Asp (RGD)-Modified E1A/E1B Double Mutant Adenovirus Enhances Antitumor Activity in Prostate Cancer Cells In Vitro and in MiceAssociations of body mass index, smoking, and alcohol consumption with prostate cancer mortality in the Asia Cohort Consortium3p21.3 tumor suppressor gene RBM5 inhibits growth of human prostate cancer PC-3 cells through apoptosis.A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer.Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo.The multikinase inhibitor sorafenib induces caspase-dependent apoptosis in PC-3 prostate cancer cellsProstate cancer: an emerging threat to the health of aging men in AsiaNew agonist- and antagonist-based treatment approaches for advanced prostate cancer.Diffusion-weighted MRI in early assessment of tumour response to radiotherapy in high-risk prostate cancer.Genetic Variations in Inflammatory Response Genes and Their Association with the Risk of Prostate Cancer.Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α.Enzalutamide in castration-resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trial.Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
P2860
Q26749077-AA57DA83-1EC8-49C5-BA30-FA6090BE216BQ26795589-88C1B27C-E89B-4498-87DE-BF505BD1FD0BQ26827438-07EE951C-5A7E-4AB3-8183-8736632E9DAEQ32179802-883C87FA-9F60-42CF-B211-2EB48085682DQ33791760-B44C3E7A-120F-4427-BC58-9DE17D68610DQ35538436-EB7B3B60-DEA9-4DF7-8FEC-916B63C20DBDQ35890708-65C378D4-028B-4293-B40D-932C0BED159DQ35901283-BC73C77A-DE5D-40DF-B87C-BB6ED9B84CB5Q36276912-98973242-BD51-4ED0-B92A-B1321A191497Q36531482-74528342-A4FB-4A36-8AD0-E0D4ECFC8E5AQ37084150-717820A6-2513-4CBA-8F6F-09643B8A971BQ37084635-4A2B0E46-606F-4C36-9800-C8862B0DD2CDQ37084695-71EEE284-9B6E-440F-8577-19AF07F2E954Q37085343-0AD357AA-FA6C-4E30-B7B6-CC4DDF7F8766Q38042768-4E6EACE1-FB68-4148-BBDE-6635C8FCF317Q41881716-2712FD3F-1E2E-404E-A5FE-C3701DC275F7Q41888259-1679273A-D520-427F-BF57-BE6E88995F7CQ45324940-2FD58461-CAC7-4CF4-9206-A22C208D3524Q46131083-D9063E8D-4424-4612-9316-08115ABB4E80Q54306535-0AC99310-8D86-4B9A-AA5B-D3013AE15E93
P2860
Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diagnostic strategies and the ...... ce of prostate cancer in China
@en
Diagnostic strategies and the ...... e of prostate cancer in China.
@nl
type
label
Diagnostic strategies and the ...... ce of prostate cancer in China
@en
Diagnostic strategies and the ...... e of prostate cancer in China.
@nl
prefLabel
Diagnostic strategies and the ...... ce of prostate cancer in China
@en
Diagnostic strategies and the ...... e of prostate cancer in China.
@nl
P2093
P2860
P356
P1476
Diagnostic strategies and the ...... ce of prostate cancer in China
@en
P2093
Li-Rong Guo
Ling Zhang
Xue-Jian Zhao
P2860
P356
10.1038/AJA.2008.21
P577
2008-12-01T00:00:00Z